PyInvesting

Market research

1066.HK Shandong Weigao Group Medical Polymer Company Limited

HK HKD Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
15B
P/E ratio
8.02
Analyst target
5.3069
Dividend yield
4.3%
Beta
0.36

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Shandong Weigao Group Medical Polymer Company Limited is currently in a long term uptrend where the price is trading 7.2% above its 200 day moving average.

From a valuation standpoint, the stock is 95.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.1.

Shandong Weigao Group Medical Polymer Company Limited's total revenue rose by 15.4% to $6B since the same quarter in the previous year.

Its net income has increased by 16.8% to $1B since the same quarter in the previous year.

Finally, its free cash flow fell by 14.4% to $518M since the same quarter in the previous year.

Based on the above factors, Shandong Weigao Group Medical Polymer Company Limited gets an overall score of 4/5.